Dea Belazi, PharmD, MPH, is a member of FierceHealthcare's Editorial Advisory Council. He is the President & CEO of AscellaHealth.
Dea has a strong background in the development and management of pharmacy benefit management companies. He served as a senior executive and played a key role in the growth and expansion of PerformRx, a PBM owned by Keystone First Health Plan. Additionally, Dea held a leadership position at Future Scripts, an Independence Blue Cross company that was sold to Catamaran.
A respected industry professional, Dea is often invited as a reviewer for multiple medical journals and holds a seat on the Board of Directors for numerous healthcare-related companies.
Dea secured a post-doctorate health outcomes research fellowship at Thomas Jefferson University, and earned a PharmD from the University of RI. He completed dissertational work at Brown University and later completed an MPH from Johns Hopkins University.